Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1960卷 / 1期

关键词：

D O I：

10.1007/s40278-023-40933-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：105 / 105

相关论文

共 50 条

[1] Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis: 21 case reports
Reactions Weekly, 2011, 1377 (1) : 11 - 11
[2] Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis following intravitreal administration: 19 case reports
Reactions Weekly, 2012, 1419 (1) : 12 - 12
[3] Pegaptanib/ranibizumab/triamcinoloneEndophthalmitis and uveitis: 11 case reports
Reactions Weekly, 2013, 1433 (1) : 33 - 33
[4] Bevacizumab/cetuximabIntestinal anastomosis site leakage: 14 case reports
Reactions Weekly, 2023, 1953 (1) : 111 - 111
[5] TriamcinoloneEndophthalmitis: case report
Reactions Weekly, 2017, 1656 (1) : 454 - 454
[6] Bevacizumab/paclitaxelDysphonia: 4 case reports
Reactions Weekly, 2014, 1518 (1) : 47 - 47
[7] Bevacizumab/ranibizumabEndophthalmitis: 5 case reports
Reactions Weekly, 2015, 1547 (1) : 60 - 60
[8] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
Reactions Weekly, 2013, 1444 (1) : 11 - 11
[9] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
Reactions Weekly, 2015, 1576 (1) : 61 - 61
[10] Bevacizumab/ranibizumabEndophthalmitis: 16 case reports
Reactions Weekly, 2016, 1592 (1) : 49 - 49

← 1 2 3 4 5 →